Jan 27, 2025, 09:44
David Planchard: Resistance to targeted therapies in the lung from a clinical and translational research angle
David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay, Head of the Thoracic Group and CICT at the Department of Medical Oncology, shared a post on LinkedIn:
“It’s a pleasure to hear Profs Rolf Stahel and Triparna sen talk about resistance to targeted therapies in the lung (particularly EGFR) from a clinical and translational research angle.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 25, 2025, 16:56
Feb 25, 2025, 15:10
Feb 25, 2025, 14:12
Feb 25, 2025, 14:04
Feb 25, 2025, 13:56
Feb 25, 2025, 13:46
Feb 25, 2025, 13:38